Gobinda Sarkar

10.5k total citations · 2 hit papers
114 papers, 6.2k citations indexed

About

Gobinda Sarkar is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gobinda Sarkar has authored 114 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 21 papers in Genetics and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gobinda Sarkar's work include Molecular Biology Techniques and Applications (16 papers), RNA and protein synthesis mechanisms (13 papers) and Cancer-related gene regulation (10 papers). Gobinda Sarkar is often cited by papers focused on Molecular Biology Techniques and Applications (16 papers), RNA and protein synthesis mechanisms (13 papers) and Cancer-related gene regulation (10 papers). Gobinda Sarkar collaborates with scholars based in United States, Japan and Switzerland. Gobinda Sarkar's co-authors include S S Sommer, Mark E. Bolander, Steve S. Sommer, Dindyal Mandal, Priyabrata Mukherjee, Debabrata Mukhopadhyay, D.D. Koeberl, William J. Greenleaf, Mary B. Goldring and James F. Greenleaf and has published in prestigious journals such as Nature, Science and Nucleic Acids Research.

In The Last Decade

Gobinda Sarkar

112 papers receiving 5.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The "megaprimer" method of site-directed mutagenesis.

1990 1.1k citations Gobinda Sarkar et al. profile →
The use of microorganisms for the formation of metal nanoparticles and their application

2005 752 citations Mark E. Bolander, Gobinda Sarkar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gobinda Sarkar United States	37	3.3k	948	935	839	536	114	6.2k
Josef Kellermann Germany	41	3.3k 1.0×	430 0.5×	406 0.4×	440 0.5×	499 0.9×	125	5.5k
Karel Smetana Czechia	41	4.1k 1.2×	481 0.5×	427 0.5×	555 0.7×	1.2k 2.2×	418	7.6k
Yiping Li China	45	3.7k 1.1×	542 0.6×	435 0.5×	934 1.1×	911 1.7×	162	6.5k
Marie‐Claude Hofmann United States	42	2.0k 0.6×	1.7k 1.8×	984 1.1×	467 0.6×	485 0.9×	91	6.1k
Christopher M. Reilly United States	42	2.4k 0.7×	487 0.5×	1.2k 1.3×	493 0.6×	448 0.8×	144	6.5k
Walter Sebald Germany	62	6.6k 2.0×	858 0.9×	299 0.3×	1.3k 1.6×	1.1k 2.0×	201	10.8k
Robert Stern United States	55	4.5k 1.4×	849 0.9×	177 0.2×	741 0.9×	608 1.1×	140	11.1k
Erhard Hohenester United Kingdom	54	4.3k 1.3×	632 0.7×	452 0.5×	327 0.4×	780 1.5×	97	8.2k
Michel Goldberg France	37	3.8k 1.1×	415 0.4×	1.2k 1.2×	414 0.5×	229 0.4×	130	6.0k
He Meng China	44	2.4k 0.7×	465 0.5×	1.3k 1.4×	1.2k 1.4×	143 0.3×	168	6.5k

Countries citing papers authored by Gobinda Sarkar

Since Specialization

Citations

This map shows the geographic impact of Gobinda Sarkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gobinda Sarkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gobinda Sarkar more than expected).

Fields of papers citing papers by Gobinda Sarkar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gobinda Sarkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gobinda Sarkar. The network helps show where Gobinda Sarkar may publish in the future.

Co-authorship network of co-authors of Gobinda Sarkar

This figure shows the co-authorship network connecting the top 25 collaborators of Gobinda Sarkar. A scholar is included among the top collaborators of Gobinda Sarkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gobinda Sarkar. Gobinda Sarkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Panda, Arijit, Milovan Šuvakov, Jessica Mariani, et al.. (2023). Clonally Selected Lines After CRISPR-Cas Editing Are Not Isogenic. The CRISPR Journal. 6(2). 176–182. 4 indexed citations

Tapryal, Nisha, Anirban Chakraborty, Koa Hosoki, et al.. (2021). Intrapulmonary administration of purified NEIL2 abrogates NF-κB–mediated inflammation. Journal of Biological Chemistry. 296. 100723–100723. 14 indexed citations

Espedal, Heidi, Olivier Keunen, Tine V. Karlsen, et al.. (2019). Improved Drug Delivery to Brain Metastases by Peptide-Mediated Permeabilization of the Blood–Brain Barrier. Molecular Cancer Therapeutics. 18(11). 2171–2181. 18 indexed citations

Gupta, Shiv K., Sani H. Kizilbash, Brett L. Carlson, et al.. (2015). Delineation ofMGMTHypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma. JNCI Journal of the National Cancer Institute. 108(5). djv369–djv369. 93 indexed citations

Meng, Yu, István Sohár, David E. Sleat, et al.. (2013). Effective Intravenous Therapy for Neurodegenerative Disease With a Therapeutic Enzyme and a Peptide That Mediates Delivery to the Brain. Molecular Therapy. 22(3). 547–553. 40 indexed citations

Bender, Aaron M., Lara S. Collier, Fausto J. Rodríguez, et al.. (2010). Sleeping Beauty –Mediated Somatic Mutagenesis Implicates CSF1 in the Formation of High-Grade Astrocytomas. Cancer Research. 70(9). 3557–3565. 52 indexed citations

Ellison, Jay W., Marineh Yagubyan, Ramanath Majumdar, et al.. (2007). Evidence of Genetic Locus Heterogeneity for Familial Bicuspid Aortic Valve. Journal of Surgical Research. 142(1). 28–31. 19 indexed citations

Srivastava, Alok, Bruno Fuchs, Kunbo Zhang, et al.. (2006). High WT1 Expression Is Associated with Very Poor Survival of Patients with Osteogenic Sarcoma Metastasis. Clinical Cancer Research. 12(14). 4237–4243. 32 indexed citations

Yamagiwa, H, Mark E. Bolander, & Gobinda Sarkar. (2004). Evaluation of Different Conditions for Ligating Dumbbell-Shaped Oligonucleotides. Molecular Biotechnology. 26(2). 111–116. 1 indexed citations

10.

Zhang, Kunbo, Norbert Dion, Bruno Fuchs, et al.. (2002). The human homolog of yeast SEP1 is a novel candidate tumor suppressor gene in osteogenic sarcoma. Gene. 298(2). 121–127. 19 indexed citations

11.

Sanyal, Arunik, Gobinda Sarkar, Daniël B.F. Saris, et al.. (2000). Initial Evidence for the Involvement of Bone Morphogenetic Protein-2 Early during Periosteal Chondrogenesis. Journal of Bone and Joint Surgery. 82(10). 16–16. 1 indexed citations

12.

Fuchs, Bruno, Kunbo Zhang, Michael G. Rock, Mark E. Bolander, & Gobinda Sarkar. (1999). Repeat cDNA Synthesis and RT-PCR with the Same Source of RNA. Molecular Biotechnology. 12(3). 231–236. 1 indexed citations

13.

Schimke, Jill M., Olle Ljungqvist, Gobinda Sarkar, Cheryl A. Conover, & K. Sreekumaran Nair. (1999). A quantitative PCR measurement of messenger RNA expression of IGF-I, IGF-II and IGFBP-5 in human skeletal muscle. Growth Hormone & IGF Research. 9(3). 179–186. 13 indexed citations

14.

Sanyal, Arunik, Shawn W. O’Driscoll, Mark E. Bolander, & Gobinda Sarkar. (1997). An effective method of completely removing contaminating genomic DNA from an RNA sample to be used for PCR. Molecular Biotechnology. 8(2). 135–137. 20 indexed citations

15.

Strausbauch, Michael, et al.. (1995). A novel method for sequencing members of multi-gene families. Nucleic Acids Research. 23(15). 3074–3075. 6 indexed citations

16.

Sur, Sanjiv, Gerald J. Gleich, Mark E. Bolander, Deborah A. Weiler, & Gobinda Sarkar. (1994). Comparative evaluation of quantitative polymerase chain reaction methods. The FASEB Journal. 8. 509. 1 indexed citations

17.

Bottema, C. D. K., Gobinda Sarkar, Joslyn Cassady, et al.. (1993). [29] Polymerase chain reaction amplification of specific alleles: A general method of detection of mutations, polymorphisms, and haplotypes. Methods in enzymology on CD-ROM/Methods in enzymology. 218. 388–402. 65 indexed citations

18.

Jalal, S. M., et al.. (1993). Absence of chromosome fragility at 19q13.3 in patients with myotonic dystrophy. American Journal of Medical Genetics. 46(4). 441–443. 14 indexed citations

19.

Sarkar, Gobinda, et al.. (1992). Screening for mutations by RNA single-strand conformation polymorphism (rSSCP): comparison with DNA-SSCP. Nucleic Acids Research. 20(4). 871–878. 137 indexed citations

20.

Sarkar, Gobinda, et al.. (1985). Identification of a new polypeptide coded by reovirus gene S1. Journal of Virology. 54(3). 720–725. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact